2.295USD+0.66%Mkt Cap: 8.38M USDP/E: —Last update: 2026-06-01
Enveric Biosciences, Inc., a biotechnology company, focuses on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States. Its …
Industry Peers
BiotechnologyIndicators:|
Key Statistics
Company
Market Cap8.38M USD
Enterprise Value3.56M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-8.77M USD
Revenue/Share—
Last Price2.295 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees5
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS29405E2081
Valuation
P/E (Trailing)—
P/E (Forward)-1.63
PEG—
EV/EBITDA-0.44
EV/Revenue—
P/S—
P/B0.58
EPS (TTM)-22.74
EPS (Forward)-1.41
52W Range
1.7104% of range17.64
52W High17.64 USD
52W Low1.710 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-209.98%
ROA-172.14%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.14M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-58.60%
Net Debt-4.91M USD
Net Debt/EBITDA0.61
Balance Sheet
Debt/Equity—
Current Ratio11.67
Quick Ratio10.66
Book Value/Sh3.935 USD
Cash/Share1.333 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateApr 23, 2008
Pay DateNov 25, 2019
Splits
Last Split1:12
Split DateOct 28, 2025
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.3.68M
Float3.64M
Insiders2.15%
Institutions4.46%
Short Interest
Short Ratio0.0d
Short % Float3.19%
Short % Out.3.15%
Shares Short115.97K
Short (prev mo.)63.02K
Technical
SMA 502.655 (-13.6%)
SMA 2005.491 (-58.2%)
Beta1.23
S&P 52W Chg27.94%
Avg Vol (30d)7.52M
Avg Vol (10d)203.81K
Technical Indicators
RSI (14)41.2
MACD-0.2320
MACD Signal-0.1855
MACD Hist.-0.0465
BB Upper3.715 USD
BB Middle2.616 USD
BB Lower1.517 USD
BB Width84.03%
ATR (14)0.4059 USD
Vol Ratio (20d)0.19x